PA-824

本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断

抑制蛋白质和细胞壁脂质合成的抗结核药；对复制型和静态型结核分枝杆菌均具有杀菌活性（MIC：0.015-0.25 ug/mL）。

A anti-tuberculosis agent that inhibits the synthesis of protein and cell wall lipid; exhibits bactericidal activity against both replicating and static M. tuberculosis (MIC: 0.015-0.25 ug/mL); shows potent bactericidal activity against MDR M. tuberculosis and promising oral activity in animal infection models.

——

——

PA824 | PA 824 | Pretomanid | (S)-PA 824

GPCR/G Protein

Antibacterial

tuberculosis

Infection

——

187235-37-6

359.2574

C14H12F3N3O5

>98% (HPLC)

DMSO: ≥ 33 mg/mL

FC(F)(F)OC1=CC=C(C=C1)CO[C@H]2CN3C(OC2)=NC([N+]([O-])=O)=C3

5H-Imidazo[2,1-b][1,3]oxazine, 6,7-dihydro-2-nitro-6-[[4-(trifluoromethoxy)phenyl]methoxy]-, (6S)-

(-20℃)

With Ice Pack

≥ 2 years